Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

Author(s):  
Yoon-Kyoung Sung ◽  
Young Ho Lee
Sign in / Sign up

Export Citation Format

Share Document